Cytokine Expression of Microscopic Colitis Including Interleukin-17
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Microscopic colitis is characterized by chronic watery diarrhea with specific pathological changes that can be diagnosed by microscopic examination. We performed immunohistochemical analysis of proinflammatory cytokines to investigate the pathogenic mechanism of microscopic colitis. Methods: This study consisted of six patients with lymphocytic colitis, six patients with collagenous colitis, and six patients with functional diarrhea but normal pathology. We performed an immunohistochemical analysis of the colonic mucosal biopsies to assess the expression of cyclo-oxygenase-2, interleukin-17, nuclear factor-κB, interferon-γ, inducible nitric oxide synthase, and tumor necrosis factor-α. We compared the quantity score of immunohistochemical staining among the groups. Results: The microscopic colitis group showed significantly higher expression of cyclo-oxygenase-2, interleukin-17, nuclear factor-κB, and interferon-γ compared with the control group. Cytokine expression was similar between collagenous colitis and lymphocytic colitis. However, the expression of cyclo-oxygenase-2 was higher in collagenous colitis. Conclusions: Proinflammatory cytokines, including interleukin-17 and interferon-γ, are highly expressed in microscopic colitis. The expression of cyclo-oxygenase-2 was higher in collagenous colitis than in lymphocytic colitis. This study is the first on interleukin-17 expression in microscopic colitis patients.
Abstract
Background/Aims: Microscopic colitis is characterized by chronic watery diarrhea with specific pathological changes that can be diagnosed by microscopic examination. We performed immunohistochemical analysis of proinflammatory cytokines to investigate the pathogenic mechanism of microscopic colitis. Methods: This study consisted of six patients with lymphocytic colitis, six patients with collagenous colitis, and six patients with functional diarrhea but normal pathology. We performed an immunohistochemical analysis of the colonic mucosal biopsies to assess the expression of cyclo-oxygenase-2, interleukin-17, nuclear factor-κB, interferon-γ, inducible nitric oxide synthase, and tumor necrosis factor-α. We compared the quantity score of immunohistochemical staining among the groups. Results: The microscopic colitis group showed significantly higher expression of cyclo-oxygenase-2, interleukin-17, nuclear factor-κB, and interferon-γ compared with the control group. Cytokine expression was similar between collagenous colitis and lymphocytic colitis. However, the expression of cyclo-oxygenase-2 was higher in collagenous colitis. Conclusions: Proinflammatory cytokines, including interleukin-17 and interferon-γ, are highly expressed in microscopic colitis. The expression of cyclo-oxygenase-2 was higher in collagenous colitis than in lymphocytic colitis. This study is the first on interleukin-17 expression in microscopic colitis patients.
참고문헌 (27)
- Andresen L, "Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis", Gut, 54, pp.503~509 (2005)
- Kao KT, "Microscopic colitis: a large retrospective analysis from a health maintenance organization experience", World J Gastroenterol, 15, pp.3122~3127 (2009)
- Loftus EV, "Microscopic colitis: epidemiology and treatment", Am J Gastroenterol, 98(12), pp.S31~S36 (2003)
- Thomson RD, "Lansoprazole-associated microscopic colitis: a case series", Am J Gastroenterol, pp.2908~2913 (2002)
- Yagi K, "Nonsteroidal anti-inflammatory drug-associated colitis with a histology of collagenous colitis", Endoscopy, 33, pp.629~632 (2001)
- Tagkalidis PP, "Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile", J Clin Pathol, 60, pp.382~387 (2007)
- Perner A, "Expression of nitric oxide synthases and effects of L-arginine and L-NMMA on nitric oxide production and fluid transport in collagenous colitis", Gut, 49, pp.387~394 (2001)
- Wildt S, "Cyclooxygenase-2 immunoreactivity in collagenous colitis", APMIS, 117, pp.500~506 (2009)
- Lazenby AJ, "Lymphocytic (“microscopic”) colitis: a comparative histopathologic study with particular reference to collagenous colitis", Hum Pathol, 20, pp.18~28 (1989)
- Giardiello FM, "The atypical colitides", Gastroenterol Clin North Am, 28, pp.479~490 (1999)
- Jessurun J, "Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathologic findings in 15 patients", Hum Pathol, 18, pp.839~848 (1987)
- Dey I, "Lymphocytic colitis is associated with increased pro-inflammatory cytokine profile and up regulation of prostaglandin receptor EP4", PLoS One, 8, pp.e61891~ (2013)
- Wallace JL, "Prostaglandin biology in inflammatory bowel disease", Gastroenterol Clin North Am, 30, pp.971~980 (2001)
- Hendel J, "Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease", Am J Gastroenterol, 92, pp.1170~1173 (1997)
- Müller-Decker K, "Cellular localization of cyclo-oxygenase isozymes in Crohn’s disease and colorectal cancer", Int J Colorectal Dis, 14, pp.212~218 (1999)
- Singer II, "Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease", Gastroenterology, 115, pp.297~306 (1998)
- Roberts PJ, "Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease", Gut, 48, pp.468~472 (2001)
- Kumawat AK, "Microscopic colitis patients demonstrate a mixed Th17", Tc17 and Th1, Mol Immunol, pp.2013, 55[DOI]
- Kim SW, "Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease", Gut, 60, pp.1527~1536 (2011)
- Zhang Z, "Critical role of IL-17 receptor signaling in acute TNBS-induced colitis", Inflamm Bowel Dis, 12, pp.382~388 (2006)
- Strzępa A, "IL-17-expressing cells as a potential therapeutic target for treatment of immunological disorders", Pharmacol Rep, 63, pp.30~44 (2011)
- Fitzpatrick LR, "Novel pharmacological approaches for inflammatory bowel disease: targeting key intracellular pathways and the IL-23", IL-17 axis, 2012, pp.2012, 389404~
- Casellas i Jordà F, "TNF-alpha inhibitors in inflammatory bowel disease", Med Clin, 123, pp.627~634 (2004)
- Ullman TA, "Intestinal inflammation and cancer", Gastroenterology, 140, pp.1807~1816 (2011)
- Malik T, "Inflammatory bowel diseases: emerging therapies and promising molecular targets", Front Biosci, 4, pp.1172~1189 (2012)
- Esteve M, "Efficacy of anti-TNF therapies in refractory severe microscopic colitis", J Crohns Colitis, 5, pp.612~618 (2011)
- Aram G, "Refractory lymphocytic enterocolitis and tumor necrosis factor antagonist therapy", Clin Gastroenterol Hepatol, 8, pp.391~394 (2010)